Quibim’s flagship solution, which uses biopsy data for training, has received 510(k) clearance for use in the United States ...

Quibim’s flagship solution, which uses biopsy data for training ... cancer detection and treatment. QP-Prostate, which uses algorithms trained on actual pathology data as ground truth, already ...

This could potentially be used as a standalone pan-cancer test or, given its low false positive rate among healthy people, be licensed out for use in conjunction with other liquid biopsy ...

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...

We are getting that second biopsy. Again, we have a very decent success rate there with about a third of the patients, but we're not getting that on everyone and sadly for prostate we haven't ...

New data from one such partnership demonstrating the performance of the VeriStrat test in advanced prostate cancer was presented at the AACR Liquid Biopsy meeting in San Diego in the fourth quarter.

He referred her to an ENT consultant in Woking, Surrey, who looked down her throat with an endoscope camera and took a biopsy for testing ... cancer alongside prostate, breast and bowel ...